Search:

Health Care & Hospitals Headlines from PR Newswire


Marapharm Ventures Inc. Pays Off Mortgage on Las Vegas, Nevada Property
New Data Show High Adherence Rates with Pradaxa® (dabigatran etexilate mesylate) in NVAF Patients
SystemOne and Daktari Announce Partnership to Bring Connected Diagnostics to Developing World
Skills® for Autism Wins Gold at the Learning Technologies Awards
CSL Behring Presents New Phase III Analysis of IDELVION® for Hemophilia B at the 2016 American Society of Hematology Annual Meeting
Novartis presents results from first global registration trial of CTL019 in pediatric and young adult patients with r/r B-ALL
In Clinical Trials, CAR T Cell Immunotherapy Continues to Yield Complete Responses in Children & Young Adults with Relapsed and Refractory Leukemia
Data at ASH 2016 Show Strong, Lasting Efficacy of IMBRUVICA® (ibrutinib) Through Five Years of Treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
IMBRUVICA® (ibrutinib) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 5-Year Analysis and Long-Term RESONATE-2 Follow-up Data at ASH 2016 Show Lasting Efficacy
Dr. Andre Goy and Cota will present "Impact of Charlson Comorbidity Index (CCI) and Refining the MIPI Index in Mantle Cell Lymphoma" at 58th American Society of Hematology Annual Meeting & Exposition
St. Jude Memphis Marathon® Weekend raises $10 million for kids battling cancer, other life-threatening diseases at St. Jude Children's Research Hospital®
Studies Advance a More Personalized Approach to Treatment
Novartis SEG101 (crizanlizumab, formerly SelG1) significantly reduces frequency of sickle cell pain crises in Phase II study
Sickle Cell Disease Research Shows Progress in Preventing Related Complications and Death
Pairnomix Presents Systematic Approach To Identifying Approved Drugs That May Be Repurposed For Treatment Of Rare Genetic Diseases
Control Of The Tan Company, MassageLuXe, Xist Fitness, LifeXist And BAM Brands Turned Over To Mark Otter
After One Dose of Gene Therapy, Hemophilia B Patients Maintain Near-Normal Levels of Clotting Factor
Bioengineering Innovations Show Promise for Improving Treatments and Drug Delivery
ZIMMER BIOMET (ZBH) ALERT: Johnson & Weaver, LLP Announces Filing of Class Action Complaint Against Zimmer Biomet Holdings, Inc.; Encourages all Investors to Contact the Firm for Information
LANNETT INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Lannett Company, Inc. - LCI
Sovereign Health Examines Insurance and Other Barriers That Affect Addiction Treatment
Shire Reports on Four Decades of Real-World Safety Experience With FEIBA® [Anti-Inhibitor Coagulant Complex]
This holiday season give the gift of health
Amgen Announces Launch Of Blood Counts™ And Collaboration With StoryCorps To Record And Share Stories Of Those Impacted By Multiple Myeloma
Schlesinger Fund For Global Health Entrepreneurship At Babson College To Host Haitian Entrepreneur Pitch Event
Georgia Dental Association Endorses U.S. Rep. Tom Price, M.D., HHS Nomination
DNA Diagnostics Center® Announces Acquisition of IDENTIGENE®, LLC
Native American Public Health Policy Expert Joins March Of Dimes National Board Of Trustees Spanish
DaVita Launches Joint Venture with Inspira Health Network to Provide Dialysis Services in South Jersey
Facebook, Microsoft Philanthropies, Google And Qualcomm Wireless Reach Featured At Annual Global Digital Health Forum Closing Plenary
New England Biolabs® Passion in Science Awards® Recipients Are Redefining What it Means to Be a Scientist in Today's World
John Theurer Cancer Center Presents Groundbreaking Studies in Blood Cancer at American Society of Hematology Meeting
Global biopharma investment kicks off at Biotech Showcase™ 2017 in January
Veterans Explore Glass Artistry with Wounded Warrior Project
FDA approves Jardiance to reduce cardiovascular death in adults with type 2 diabetes
Groundbreaking MMRF CoMMpass Study(SM) Affirmed as Premier Genomics Data Set in Multiple Myeloma
Linde Targets Productivity of Mixer Chilling with Hygienic LIXSHOOTER® Bottom Injectors
11th Double Helix Medals raises $4.3 million for biomedical research and education at Cold Spring Harbor Laboratory
Landmark Autism Genetic Study Seeking Participants
A Smooth Way to Start Your Day
Online R&D Drug Pipeline Database: Access to Information About 21,000+ Project Entries for Therapeutic Drugs - Research and Markets
CVS Health To Host 2016 Analyst Day For The Investment Community
PriMed Management Consulting Services Names New CFO, Tim Richards
Quantum Radiology's Mobile Breast Center Has Rolled into Atlanta
In Vitro Diagnostics/IVD Market Worth 78.74 Billion USD by 2021
Cota Names Scott Paddock as Executive Vice President, General Manager, and Chief Revenue Officer
Banfield Pet Hospital® Presented With Leading Environmental Practice Award
New Research Center Aims to Improve Community Health
Global Nanobiotechnology Report 2015-2025 - Focus on Applications, Markets and Companies with Profiles of 250+ Companies - Research and Markets
Topline Results of Phase 3 Investigational Study of VONVENDI™ [von Willebrand factor (recombinant)] Meets Primary Endpoint Effectively Controlling Bleeding and Blood Loss During Surgical Procedures

< Prev Next >
PR Newswire - United Business Media